TerminatedNot applicableNCT00608517
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
Studying Acute mast cell leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Principal Investigator
- Brian Engelhardt, MDVanderbilt-Ingram Cancer Center
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 6 enrolled
- Eligibility
- 50 years · All sexes
- Timeline
- 2005 – 2011
Study locations (4)
- Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center at Franklin, Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Nashville, Nashville, Tennessee, United States
- Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00608517 on ClinicalTrials.govOther trials for Acute mast cell leukemia
Additional recruiting or active studies for the same condition.